The internal mechanisms of the Washington lobbying game were inadvertently placed on public display Tuesday during a House committee hearing on an Obama Administration move to reduce prescription drug costs. Two witnesses opposing the proposal, ostensibly from two different interest groups, somehow submitted statements that contained identical passages.
They were outed by Rep. Jan Schakowsky (D-Ill.), who said she found the similarities “very curious.”
But it wasn’t such a mystery. Both groups are represented by the same Washington lobbying shop, Hart Health Strategies, which prepared their witness statements. Hart represents a passel of doctor and patient advocacy organizations in Washington as well as pharmaceutical companies, which may provide a clue to what was really going on here.
(Read the rest here.)